JP2017520547A5 - - Google Patents

Download PDF

Info

Publication number
JP2017520547A5
JP2017520547A5 JP2016572800A JP2016572800A JP2017520547A5 JP 2017520547 A5 JP2017520547 A5 JP 2017520547A5 JP 2016572800 A JP2016572800 A JP 2016572800A JP 2016572800 A JP2016572800 A JP 2016572800A JP 2017520547 A5 JP2017520547 A5 JP 2017520547A5
Authority
JP
Japan
Prior art keywords
formula
compound
hydrogen
alkyl
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016572800A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017520547A (ja
JP6785666B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/063942 external-priority patent/WO2015197534A2/en
Publication of JP2017520547A publication Critical patent/JP2017520547A/ja
Publication of JP2017520547A5 publication Critical patent/JP2017520547A5/ja
Application granted granted Critical
Publication of JP6785666B2 publication Critical patent/JP6785666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016572800A 2014-06-23 2015-06-22 1,3−ベンゾジオキソール複素環化合物の調製方法 Active JP6785666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14173397.2 2014-06-23
EP14173397 2014-06-23
PCT/EP2015/063942 WO2015197534A2 (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Publications (3)

Publication Number Publication Date
JP2017520547A JP2017520547A (ja) 2017-07-27
JP2017520547A5 true JP2017520547A5 (OSRAM) 2018-07-26
JP6785666B2 JP6785666B2 (ja) 2020-11-18

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016572800A Active JP6785666B2 (ja) 2014-06-23 2015-06-22 1,3−ベンゾジオキソール複素環化合物の調製方法

Country Status (18)

Country Link
US (1) US9908894B2 (OSRAM)
EP (1) EP3157930B1 (OSRAM)
JP (1) JP6785666B2 (OSRAM)
KR (1) KR20170016894A (OSRAM)
CN (1) CN106459081B (OSRAM)
AU (1) AU2015279428B2 (OSRAM)
BR (1) BR112016029510A2 (OSRAM)
CA (1) CA2953284A1 (OSRAM)
DK (1) DK3157930T3 (OSRAM)
ES (1) ES2702451T3 (OSRAM)
IL (1) IL249336A0 (OSRAM)
MX (1) MX2016016378A (OSRAM)
PL (1) PL3157930T3 (OSRAM)
PT (1) PT3157930T (OSRAM)
RU (1) RU2697251C2 (OSRAM)
TW (1) TW201613934A (OSRAM)
WO (1) WO2015197534A2 (OSRAM)
ZA (1) ZA201608442B (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3390407T3 (pl) 2015-12-18 2024-01-29 UNION therapeutics A/S Sposoby otrzymywania heterocyklicznych związków 1,3-benzodioksolu
DK3642210T3 (da) * 2017-06-20 2024-12-09 Union Therapeutics As Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser
EP3724196B9 (en) 2017-12-15 2023-03-22 UNION therapeutics A/S Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
AU2020208761B2 (en) 2019-01-15 2025-03-13 UNION therapeutics A/S Modified release tablet formulations containing phosphodiesterase inhibitors
CA3212316A1 (en) 2021-03-22 2022-09-29 Morten Sommer Treatment of hidradenitis suppurativa with orismilast
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
AU705690B2 (en) * 1995-05-19 1999-05-27 Kyowa Hakko Kogyo Co. Ltd. Oxygen-containing heterocyclic compounds
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
JPWO2004005276A1 (ja) * 2002-07-03 2005-11-04 協和醗酵工業株式会社 1,3−ベンゾジオキソール−2−スピロシクロアルカン誘導体の製造法
WO2008006509A1 (en) * 2006-07-14 2008-01-17 Chiesi Farmaceutici S.P.A. Derivatives of 1-phenyl-2-pyridynyl alkylene alcohols as phosphodiesterase inhibitors
PT2125736E (pt) 2006-12-22 2011-07-01 Leo Pharma As Acetofenonas substituídas úteis como inibidores de pde4
MX2009009238A (es) * 2007-02-28 2009-09-08 Leo Pharma As Nuevos inhibidores de fosfodiesterasa.
UA98639C2 (en) * 2007-02-28 2012-06-11 Лео Фарма А/С Phosphodiesterase inhibitors
SI2585469T1 (sl) * 2010-06-24 2016-11-30 Leo Pharma A/S Heterociklične spojine benzodioksola ali benzodioksepina kot zaviralci fostodiesteraze
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
PL3390407T3 (pl) * 2015-12-18 2024-01-29 UNION therapeutics A/S Sposoby otrzymywania heterocyklicznych związków 1,3-benzodioksolu

Similar Documents

Publication Publication Date Title
JP2017520547A5 (OSRAM)
RU2017101808A (ru) Способы получения 1, 3-бензодиоксольных гетероциклических соединений
JP2015524406A5 (OSRAM)
JP2010501516A5 (OSRAM)
JP2018529687A5 (OSRAM)
RU2018126363A (ru) Способы получения гетероциклических соединений 1, 3-бензодиоксола
JP2017522357A5 (OSRAM)
JP2015536898A5 (OSRAM)
JP2017505801A5 (OSRAM)
JP2010513494A5 (OSRAM)
JP2012251113A5 (OSRAM)
US20170369412A1 (en) Preparative method for carboxylic acids
JP2021046426A5 (OSRAM)
JP2017533926A5 (OSRAM)
CN105566260A (zh) 一种呋塞米的制备方法
JP2016515555A5 (OSRAM)
CN109952294A (zh) 4-((6-(2-(2,4-二氟苯基)-1,1-二氟-2-羟基-3-(5-巯基-1h-1,2,4-三唑-1-基)丙基)吡啶-3-基)氧基)苄腈及制备方法
CN102351621A (zh) 一种n-砜基脒的制备方法
CN103073492A (zh) 2-[3-(s)-[3-[2-(7-氯-2-喹啉基)乙烯基]苯基]-3-羟基丙基]苯甲酸酯的合成方法
CN108147993A (zh) 一种水相合成磷钨杂多酸盐的方法
JP2005516905A5 (OSRAM)
CN105175364A (zh) 一种制备抗艾滋病药物安普那韦中间体的方法
JP2014520066A5 (OSRAM)
CN104350036B (zh) 4‑烷酰氧基‑2‑甲基丁酸的生产方法
CN106632019A (zh) 一种多取代吡啶的制备方法